137 related articles for article (PubMed ID: 21461964)
1. Frequency of HCV infection in renal cell carcinoma patients.
Budakoğlu B; Aksoy S; Arslan Ç; Üyetürk Ü; Babacan NA; Özcan MF; Yıldız R; Öven BB; Özdemir NY; Dizdar Ö; Büyükberber S; Akıncı MB; Türker I; Öksüzoğlu B; Altundag K; Zengin N
Med Oncol; 2012 Sep; 29(3):1892-5. PubMed ID: 21461964
[TBL] [Abstract][Full Text] [Related]
2. Risk for renal cell carcinoma in chronic hepatitis C infection.
Gordon SC; Moonka D; Brown KA; Rogers C; Huang MA; Bhatt N; Lamerato L
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1066-73. PubMed ID: 20332260
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C infection as a risk factor for renal cell carcinoma.
Gonzalez HC; Lamerato L; Rogers CG; Gordon SC
Dig Dis Sci; 2015 Jun; 60(6):1820-4. PubMed ID: 25592719
[TBL] [Abstract][Full Text] [Related]
4. The association between hepatitis C virus infection and renal cell cancer, prostate cancer, and bladder cancer: a systematic review and meta-analysis.
Ma Y; Huang Z; Jian Z; Wei X
Sci Rep; 2021 May; 11(1):10833. PubMed ID: 34035396
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Hepatitis C Virus Infection in Patients With Renal-Cell Carcinoma.
Rangel JCA; Rangel JB; Thuler LCS; Pinto JFDC
Clin Genitourin Cancer; 2021 Feb; 19(1):e51-e54. PubMed ID: 32893126
[TBL] [Abstract][Full Text] [Related]
6. Association between hepatitis C virus genotype 4 and renal cell carcinoma: Molecular and virological studies.
Ahmed AE; Abol-Enein H; El-Morsi AA; El-Hefnawy AS; Elsayed AA; Khater S; Hashem A; Zekri AN; Haroun SA; Shokeir AA; Awadalla A
J Basic Microbiol; 2024 Jun; 64(6):e2300279. PubMed ID: 38616711
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
9. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study.
Kocoglu H; Karaca M; Tural D; Hocaoglu E; Okuturlar Y; Fetullahoglu Z; Gunaldi M; Ciftci R; Tuna S; Yucil OK; Yuce OK; Ozet G; Ozet A; Benekli M
J Cancer Res Ther; 2018 Sep; 14():S774-S778. PubMed ID: 30249902
[TBL] [Abstract][Full Text] [Related]
11. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area.
Lee HS; Han CJ; Kim CY
Cancer; 1993 Nov; 72(9):2564-7. PubMed ID: 8402477
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.
Donato F; Boffetta P; Puoti M
Int J Cancer; 1998 Jan; 75(3):347-54. PubMed ID: 9455792
[TBL] [Abstract][Full Text] [Related]
13. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
14. HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.
Ong WL; King K; Koh TL; Chipman M; Royce P; Hoy J; Millar JL
Asia Pac J Clin Oncol; 2016 Jun; 12(2):188-93. PubMed ID: 26997617
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
18. Superinfection with hepatitis C virus in hemodialysis patients with hepatitis B surface antigenemia: its prevalence and clinical significance in Taiwan.
Chen KS; Lo SK; Lee N; Leu ML; Huang CC; Fang KM
Nephron; 1996; 73(2):158-64. PubMed ID: 8773337
[TBL] [Abstract][Full Text] [Related]
19. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and C virus infection in Crohn's disease.
Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
